PITTSBURGH–(BUSINESS WIRE)–Latticework Capital Management (“Latticework” or “LCM”), a growth oriented private equity firm focused on partnering with entrepreneurially-minded management teams to build successful healthcare companies, and Edgehill Management (“Edgehill”), a private investment firm focused on partnering with entrepreneurs and management teams, today announced a strategic investment in Life Science Connect (“LSC”).
Headquartered in Pittsburgh, Pennsylvania, LSC is a leading life science digital media business committed to enhancing connections between professionals across life science communities to accelerate research, development, manufacturing, and the application of life science innovations.
“The partnership with Latticework and Edgehill will enable our team to expand our delivery of mission-critical content to our highly engaged life science readership and continue to innovate industry-leading solutions for our clients,” said Jon Howland, CEO of LSC. “We were impressed by their commitment to bolstering the value we provide to both our readers and clients as well as their understanding of and track record in our space.”
“We are thrilled to partner with Life Science Connect to reinforce their mission of fostering collaboration among the life science ecosystem and accelerating breakthroughs in life-changing therapies and devices,” said Kyle Bradford, Managing Partner of Latticework. “We are highly impressed with the technical expertise of LSC’s senior leadership and the entire LSC staff, and we look forward to supporting LSC as they continue providing original, compelling content to a loyal readership base and driving robust business development pipelines for their strategic partners.”
Latticework has completed more than 140 transactions across a diverse array of healthcare subsectors. The firm employs a “top down” approach to investing, identifying industry themes and trends and focusing on areas of growth and opportunity.
“When we first met Life Science Connect, we were immediately impressed with their ability to facilitate outstanding outcomes across the biopharma value chain. The LSC team has built a successful platform and we are excited to help them drive further growth,” said Ben Rapaport, Edgehill’s Co-Founder.
“We are delighted to team up with Latticework on this transaction,” added Daniel Khazzam, Edgehill’s Co-Founder. “LCM’s deep expertise in healthcare, track record, and growth-minded approach to value creation enabled them to see the vision for the investment right away, and we are thrilled to join forces on our partnership with LSC.”
LSC is actively seeking acquisition opportunities to help expand their suite of capabilities for B2B sales and marketing enablement and to reach new audiences. Please contact Jon Howland ([email protected]) to connect further regarding a potential acquisition.
Latticework Capital Managing Partner Kyle Bradford, Managing Partner Steve Neumann, Principal Brett Lacher, Vice President TJ Shepard, and Associate Ruslan Gabidoulline worked on the transaction. Edgehill Management Co-Founders and Partners Daniel Khazzam and Ben Rapaport worked on the transaction.
Principal Asset ManagementSM, through its direct lending business, Principal Alternative Credit, provided the debt financing to support the acquisition and continued growth of LSC.
McGuireWoods LLP served as legal counsel to Latticework and Edgehill, Lippes Mathias LLP served as legal counsel to Edgehill, Chapman and Cutler LLP served as legal counsel to Principal, and Dentons Cohen & Grigsby PC served as legal counsel to Life Science Connect in the transaction.
About Life Science Connect:
Life Science Connect is a network of life science go-to-work solutions and communities dedicated to a better way of connecting professionals across life science communities to advance the pace of research, development, manufacturing, and use of life science innovations. Life Science Connect facilitates mutually beneficial connections between audiences and strategic partners that accelerate the advancement of life-improving, life-extending, and life-saving therapies and devices. LSC serves a loyal, professional readership that demands original, compelling content with professional applications and facilitates engagement across the drug development lifecycle through leading digital publications, events, podcasts, and more. To learn more visit www.lifescienceconnect.com.
About Latticework Capital Management:
Headquartered in Dallas, TX, with an office in Denver, CO, Latticework is a growth oriented private equity firm focused exclusively on making control equity investments in the healthcare industry. LCM has completed more than 140 transactions across a diverse array of healthcare subsectors and currently has more than $650 million in assets under management. LCM leverages its more than 100 combined years of healthcare and investing experience, as well as its network of industry executives, to help companies grow and realize their full long-term value. For more information, please visit www.latticeworkcapital.com.
About Edgehill Management:
Edgehill is a New York-based private investment firm focused on partnering with entrepreneurs and management teams of leading companies in the lower middle market. Edgehill draws on its investing and operational experience, thesis-driven diligence processes, and deep professional networks to source, execute, and manage investments. Over their careers, Edgehill’s founders have operated, invested in, and grown businesses across sectors including technology, business and consumer services, and manufacturing. For more information, please visit www.edgehill-mgmt.com.
Contacts
Jeremy Milner
BackBay Communications
[email protected]
(401) 862-9422